The largest database of trusted experimental protocols

Symbia t2 spect ct system

Manufactured by Siemens
Sourced in Germany

The Symbia T2 SPECT/CT system is a medical imaging device designed for single-photon emission computed tomography (SPECT) and computed tomography (CT) imaging. It provides integrated SPECT and CT capabilities for diagnostic procedures. The system acquires and combines SPECT and CT data to generate detailed, high-quality images for clinical assessment.

Automatically generated - may contain errors

Lab products found in correlation

3 protocols using symbia t2 spect ct system

1

SPECT/CT Imaging of I-131-chTNT Distribution

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the first day after 131I-chTNT injection, the rabbits (in the subgroup C and D) underwent SPECT/CT scanning for acquiring fusion image to observe the distribution of 131I-chTNT. The acquisition parameters of SPECT/CT (Symbia T2 SPECT/CT system, Siemens Munich, Germany) were used as follows: zoom 1.5, a 128×128 matrix with a pixel acquisition, the fusion CT acquisition used full-circle rotation, 130 kV, 35 mAs, and 5-mm slices.
+ Open protocol
+ Expand
2

SPECT Imaging with 99mTc-MIP-1404 for Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
No specific patient preparation was required except bladder voiding immediately before imaging. All patients were injected intravenously with 99mTc-MIP-1404 (mean 705 ± 61 MBq). At 2–4 h, SPECT scans were acquired on a Symbia T2 SPECT/CT system (Siemens Healthcare) from midthigh to skull vertex with low-energy high-resolution collimation, a 128 × 128 matrix with 4.8-mm pixel size, and 120 projections over 360° for 15 s per projection. SPECT scans were followed by low-dose CT (130 kV, 30 mAs) using adaptive dose modulation (CAREDose 4D; Siemens Healthcare). CT data were reconstructed with 3- and 5-mm slice thicknesses using B70s and B41s kernels for image analysis. The SPECT dataset was reconstructed using an ordered-subset expectation maximization algorithm with 4 subsets and 8 iterations, including point-spread-function modeling with CT-based attenuation correction and dual-energy window scatter correction as previously described (10 (link)). Both PET and SPECT scanners underwent routine quality control measures.
+ Open protocol
+ Expand
3

Quantitative 177Lu-SPECT Dosimetry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dosimetry was performed using quantitative 177Lu-SPECT scans of the abdomen 24, 48, and 72 h postinjection. The images were acquired over 15 min on a dual-headed Symbia T2 SPECT/CT system (Siemens Healthineers, Erlangen, Germany) as described previously [12 (link),15 (link)]. For attenuation correction, a low-dose CT scan (AC-CT) was acquired together with the first SPECT scan 24 h postinjection. The AC-CT was coregistered on the SPECT scans acquired 48 and 72 h after therapy (rigid body co-registration, PMOD Version 3.609, PMOD Technologies, Zurich, Switzerland). Quantitative SPECT reconstruction employed an in-house maximum a posteriori (MAP) algorithm with 20 iterations, 16 subsets, and a penalty factor of 0.001, as described previously [8 (link),10 (link)]. Scatter correction and resolution decompensation was applied in addition to the mentioned attenuation correction. For each patient, three to five lesions with the highest visual uptake in abdominal SPECT were evaluated. Tumor lesions were segmented semi-manually by placing volumes of interest (VOIs) with an iso-contour of 40% as proposed by Collarino et al. and confirmed by in-house phantom studies [18 (link)]. Lesion dosimetry was based on a mono-exponential fit model and mass-scaled sphere S-values (Figure 2).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!